Literature DB >> 17228282

Giant mediastinal liposarcoma: a case report.

Ajay Punpale1, C S Pramesh, Nirmala Jambhekar, Rajesh C Mistry.   

Abstract

Liposarcomas are extremely rare in the mediastinum. They may achieve considerable size before causing any symptoms. Mediastinal liposarcomas may invade surrounding structures like the pericardium or the superior vena cava. Complete surgical excision is the optimal treatment in resectable cases. Excision of adjacent structures like the pericardium may be needed if the tumor infiltrates them. We report on a case of a giant liposarcoma of the mediastinum involving both hemithoraces and extending into the neck, which was successfully managed by complete surgical excision.

Entities:  

Mesh:

Year:  2006        PMID: 17228282

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  5 in total

1.  Intraoperative radiofrequency ablation in an open thoracotomy setting for the new treatment of mediastinal liposarcoma: report of a case.

Authors:  Fumihiro Shoji; Akinobu Taketomi; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

2.  Resection of giant mediastinal liposarcoma using the hemiclamshell incision.

Authors:  Masayuki Okuno; Masahiro Kawashima; Koki Miura; Eiji Kadota; Shunsuke Goto; Motokazu Kato
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-12-18

3.  A dedifferentiated liposarcoma of the anterior mediastinum.

Authors:  Ryuta Fukai; Yuki Fukumura; Kenji Suzuki
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

4.  Primary mediastinal pleomorphic liposarcoma involving the superior vena cava.

Authors:  Gang Chen; Xiaoming Qiu; Yi Liu; Yanjie Qiao; Tao Shi; Jun Chen; Qinghua Zhou
Journal:  Thorac Cancer       Date:  2014-04-22       Impact factor: 3.500

5.  Recurrent primary mediastinal liposarcoma: A case report.

Authors:  Chun Zhao; Fangbiao Zhang; Xiangyan Zhang; Shaosong Tu; Zhijun Wu; Xia Li; Yingming Xiang; Chunhui Zheng; Qinghui Zeng
Journal:  Oncol Lett       Date:  2016-04-18       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.